The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Copper homeostasis: Emerging target for cancer treatment
Abstract
Copper (Cu) is an essential micronutrient involved in a variety of fundamental biological processes. Recently, disorder of Cu homeostasis can be observed in many malignancies. Elevated Cu levels in serum and tissue are correlated with cancer progression. Hence, targeting Cu has emerged as a novel strategy in cancer treatment. This review provides an overview of physiological Cu metabolism and its homeostasis, followed by a discussion of the dysregulation of Cu homeostasis in cancer and the effects of Cu on cancer progression. Finally, recent therapeutic advances using Cu coordination complexes as anticancer agents, as well as the mechanisms of their anti‐cancer action are discussed. This review contributes full comprehension to the role of Cu in cancer and demonstrates the broad application prospect of Cu coordination compounds as potential therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cox, T. R., Rumney, R. M. H., Schoof, E. M., Perryman, L., Høye, A. M., Agrawal, A., Bird, D., Latif, N. A., Forrest, H., Evans, H. R., et al. (2015) · Nature · doi:10.1038/nature14492 · Cited by 482
RetractedROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Prasad, S., Gupta, S. C., & Tyagi, A. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.03.042 · Cited by 978
Członkowska, A., Litwin, T., Dusek, P., Ferenci, P., Lutsenko, S., Medici, V., Rybakowski, J. K., Weiss, K. H., & Schilsky, M. L. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0018-3 · Cited by 913
Targeting copper in cancer therapy: ‘Copper That Cancer’
Denoyer, D., Masaldan, S., La Fontaine, S., & Cater, M. A. (2015) · Metallomics · doi:10.1039/c5mt00149h · Cited by 806
Copper in diseases and treatments, and copper‐based anticancer strategies
Tisato, F., Marzano, C., Porchia, M., Pellei, M., & Santini, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20174 · Cited by 797
Copper: toxicological relevance and mechanisms
Gaetke, L. M., Chow-Johnson, H. S., & Chow, C. K. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1355-y · Cited by 743
Robinson, N. J., & Winge, D. R. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030409-143539 · Cited by 708
Copper is required for oncogenic BRAF signalling and tumorigenesis
Brady, D. C., Crowe, M. S., Turski, M. L., Hobbs, G. A., Yao, X., Chaikuad, A., Knapp, S., Xiao, K., Campbell, S. L., Thiele, D. J., et al. (2014) · Nature · doi:10.1038/nature13180 · Cited by 609
Affinity gradients drive copper to cellular destinations
Banci, L., Bertini, I., Ciofi-Baffoni, S., Kozyreva, T., Zovo, K., & Palumaa, P. (2010) · Nature · doi:10.1038/nature09018 · Cited by 487
Bioavailable copper modulates oxidative phosphorylation and growth of tumors
Ishida, S., Andreux, P., Poitry-Yamate, C., Auwerx, J., & Hanahan, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318431110 · Cited by 422
The stimulation of angiogenesis and collagen deposition by copper
Gérard, C., Bordeleau, L.-J., Barralet, J., & Doillon, C. J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.009 · Cited by 420
Copper: Effects of Deficiency and Overload
Scheiber, I., Dringen, R., & Mercer, J. F. B. (2013) · Metal Ions in Life Sciences · doi:10.1007/978-94-007-7500-8_11 · Cited by 328
Brewer, G. J., Dick, R. D., Grover, D. K., LeClaire, V., Tseng, M., Wicha, M. S., Pienta, K. J., Redman, B. G., Jahan, T. M., Sondak, V. K., et al. (2000) · PubMed · Cited by 319
Cellular Copper Transport and Metabolism
Harris, E. D. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.291 · Cited by 314
Defining the human copper proteome and analysis of its expression variation in cancers
Blockhuys, S., Celauro, E., Hildesjö, C., Feizi, A., Stål, O., Fierro-González, J. C., & Wittung-Stafshede, P. (2017) · Metallomics · doi:10.1039/c6mt00202a · Cited by 294
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Ishida, S., McCormick, F., Smith-McCune, K., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.011 · Cited by 288
The roles of copper transporters in cisplatin resistance
Kuo, M. T., Chen, H. H. W., Song, I.-S., Savaraj, N., & Ishikawa, T. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9045-3 · Cited by 283
Lysyl Oxidase, Extracellular Matrix Remodeling and Cancer Metastasis
Xiao, Q., & Ge, G. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0105-z · Cited by 276
Wong, C. C.-L., Tse, A. P.-W., Huang, Y.-P., Zhu, Y.-T., Chiu, D. K.-C., Lai, R. K.-H., Au, S. L.-K., Kai, A. K.-L., Lee, J. M.-F., Wei, L. L., et al. (2014) · Hepatology · doi:10.1002/hep.27320 · Cited by 253
Shanbhag, V., Jasmer-McDonald, K., Zhu, S., Martin, A. L., Gudekar, N., Khan, A., Ladomersky, E., Singh, K., Weisman, G. A., & Petris, M. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817473116 · Cited by 233
Role of Copper in Angiogenesis and Its Medicinal Implications
Xie, H., & Kang, Y. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787846622 · Cited by 229
Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells
Baldari, S., Di Rocco, G., Heffern, M. C., Su, T. A., Chang, C. J., & Toietta, G. (2019) · Cancers · doi:10.3390/cancers11050659 · Cited by 210
Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation
Alvarez, H. M., Xue, Y., Robinson, C. D., Canalizo-Hernández, M. A., Marvin, R. G., Kelly, R. A., Mondragón, A., Penner-Hahn, J. E., & O’Halloran, T. V. (2010) · Science · doi:10.1126/science.1179907 · Cited by 204
Copper as a key regulator of cell signalling pathways
Grubman, A., & White, A. R. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.11 · Cited by 196
Role of Collagen Matrix in Tumor Angiogenesis and Glioblastoma Multiforme Progression
Mammoto, T., Jiang, A., Jiang, E., Panigrahy, D., Kieran, M. W., & Mammoto, A. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.06.026 · Cited by 193
Copper transporters and copper chaperones: roles in cardiovascular physiology and disease
Fukai, T., Ushio-Fukai, M., & Kaplan, J. H. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00132.2018 · Cited by 189
Yu, Z., Zhou, R., Zhao, Y., Pan, Y., Liang, H., Zhang, J., Tai, S., Jin, L., & Teng, C. (2019) · Cell Proliferation · doi:10.1111/cpr.12568 · Cited by 173
Yoshii, J., Yoshiji, H., Kuriyama, S., Ikenaka, Y., Noguchi, R., Okuda, H., Tsujinoue, H., Nakatani, T., Kishida, H., Nakae, D., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1537 · Cited by 170
Association between serum copper levels and lung cancer risk: A meta-analysis
Zhang, X., & Yang, Q. (2018) · Journal of International Medical Research · doi:10.1177/0300060518798507 · Cited by 168
Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells
Cater, M. A., Pearson, H. B., Wolyniec, K., Klaver, P., Bilandzic, M., Paterson, B. M., Bush, A. I., Humbert, P. O., La Fontaine, S., Donnelly, P. S., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400198p · Cited by 165
Serum Levels of Metal Ions in Female Patients with Breast Cancer
Pavithra, V., Sathisha, T. G., Kasturi, K. S., Mallika, D. S., Amos, S. J., & Ragunatha, S. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/11627.5476 · Cited by 161
Brady, D. C., Crowe, M. S., Greenberg, D. N., & Counter, C. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1190 · Cited by 160
Memo Is a Copper-Dependent Redox Protein with an Essential Role in Migration and Metastasis
MacDonald, G., Nalvarte, I., Смирнова, Т. А., Vecchi, M., Aceto, N., Doelemeyer, A., Frei, A., Lienhard, S., Wyckoff, J. B., Heß, D., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004870 · Cited by 159
Lysyl Oxidase–like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer
Salvador, F., Martín, A., López‐Menéndez, C., Moreno‐Bueno, G., Santos, V., Vázquez-Naharro, A., Santamaría, P. G., Morales, S., Dubus, P. R., Muinelo‐Romay, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3152 · Cited by 159
Blockhuys, S., Zhang, X., & Wittung-Stafshede, P. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910722117 · Cited by 153
Ostrakhovitch, E. A., Lordnejad, M. R., Schliess, F., Sies, H., & Klotz, L. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2559 · Cited by 152
16. Copper Complexes in Cancer Therapy
Denoyer, D., Clatworthy, S. A. S., & Cater, M. A. (2018) · De Gruyter eBooks · doi:10.1515/9783110470734-022 · Cited by 148
Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis
Nagaraju, G. P., Dontula, R., El‐Rayes, B. F., & Lakka, S. S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu072 · Cited by 145
Park, K. C., Fouani, L., Jansson, P. J., Wooi, D., Sahni, S., Lane, D. J. R., Palanimuthu, D., Lok, H. C., Kovačević, Ž., Huang, M., et al. (2016) · Metallomics · doi:10.1039/c6mt00105j · Cited by 141
Interaction of Human Angiogenin with Copper Modulates Angiogenin Binding to Endothelial Cells
Soncin, F., Guitton, J., Cartwright, T., & Badet, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7018 · Cited by 135
Yaman, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i4.612 · Cited by 130
Cox, C., Teknos, T. N., Barrios, M., Brewer, G. J., Dick, R. D., & Merajver, S. D. (2001) · The Laryngoscope · doi:10.1097/00005537-200104000-00024 · Cited by 124
Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents
Ekinci, E., Rohondia, S. O., Khan, R., & Dou, Q. P. (2019) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892814666190514104035 · Cited by 123
Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer
Lener, M. R., Scott, R. J., Wiechowska–Kozłowska, A., Serrano‐Fernández, P., Baszuk, P., Jaworska–Bieniek, K., Sukiennicki, G., Marciniak, W., Muszyńska, M., Kładny, J., et al. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2015.282 · Cited by 118
Shen, F., Cai, W.-S., Li, J., Feng, Z., Cao, J., & Xu, B. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0304-9 · Cited by 113
Roles of Copper-Binding Proteins in Breast Cancer
Blockhuys, S., & Wittung-Stafshede, P. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040871 · Cited by 113
Petruzzelli, R., & Polishchuk, R. (2019) · Cells · doi:10.3390/cells8091080 · Cited by 97
Serum levels of ferritin, copper, and zinc in patients with oral cancer
Mortazavi, H., Sabour, S., Baharvand, M., Manifar, S., & Akkafan, R. (2014) · Biomedical Journal · doi:10.4103/2319-4170.132888 · Cited by 96
Li, Y., Yin, J., Liu, Z., & Li, X. (2018) · IUBMB Life · doi:10.1002/iub.1722 · Cited by 95
Self-citationNovel copper complexes as potential proteasome inhibitors for cancer treatment
Zhang, Z., Wang, H., Yan, M., Wang, H., & Zhang, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6022 · Cited by 94
Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic
Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 94
Moriguchi, M., Nakajima, T., Kimura, H., Watanabe, T., Takashima, H., Mitsumoto, Y., Katagishi, T., Okanoue, T., & Kagawa, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10740 · Cited by 93
Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
Fu, S., Naing, A., Fu, C., Kuo, M. T., & Kurzrock, R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0864 · Cited by 90
12. Copper Depletion as a Therapeutic Strategy in Cancer
Lopez, J., Ramchandani, D., & Vahdat, L. T. (2019) · De Gruyter eBooks · doi:10.1515/9783110527872-018 · Cited by 90
Yaman, M., Kaya, G., & Şimşek, M. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00742.x · Cited by 86
Radiotherapy and Antiangiogenic TM in Lung Cancer
Khan, M. K., Miller, M. W., Taylor, J. M. G., Gill, N. K., Dick, R. D., Goled, K. V., Brewert, G. J., & Merajver, S. D. (2002) · Neoplasia · doi:10.1038/sj.neo.7900218 · Cited by 85
Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy
Luca, A. D., Barile, A., Arciello, M., & Rossi, L. C. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.06.008 · Cited by 82
Association between serum copper levels and cervical cancer risk: a meta-analysis
Zhang, M., Shi, M., & Zhao, Y. (2018) · Bioscience Reports · doi:10.1042/bsr20180161 · Cited by 79
Copper Is Required for Cobalt-Induced Transcriptional Activity of Hypoxia-Inducible Factor-1
Qiu, L., Ding, X., Zhang, Z., & Kang, Y. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194662 · Cited by 77
Zinc and Copper Levels in Bladder Cancer: A Systematic Review and Meta-Analysis
Mao, S., & Huang, S. (2013) · Biological Trace Element Research · doi:10.1007/s12011-013-9682-z · Cited by 74
Wadhwa, S., & Mumper, R. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.027 · Cited by 72
Cater, M. A., & Haupt, Y. (2011) · Biochemical Journal · doi:10.1042/bj20110123 · Cited by 70
Chisholm, C. L., Wang, H., Wong, A. H., Vázquez-Ortíz, G., Chen, W., Xu, X., & Deng, C. (2016) · Oncotarget · doi:10.18632/oncotarget.12992 · Cited by 69
Suska, F., Esposito, M. A., Gretzer, C., Källtorp, M., Tengvall, P., & Thomsen, P. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00359-9 · Cited by 68
Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Ressnerova, A., Raudenská, M., Holubová, M., Svobodová, M., Polanska, H. H., Babula, P., Masařík, M., & Gumulec, J. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160405111543 · Cited by 68
Kim, K., Abelman, S. H., Yano, N., Ribeiro, J. R., Singh, R. K., Tipping, M., & Moore, R. G. (2015) · Scientific Reports · doi:10.1038/srep14296 · Cited by 68
Is copper a new target to counteract the progression of chronic diseases?
Balsano, C., Porcu, C., & Sideri, S. (2018) · Metallomics · doi:10.1039/c8mt00219c · Cited by 67
Xu, M., Casio, M., Range, D. E., Sosa, J. A., & Counter, C. M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3705 · Cited by 64
Copper levels in patients with hematological malignancies
Kaiafa, G. D., Saouli, Z., Diamantidis, M. D., Kontoninas, Z., Voulgaridou, V., Raptaki, M., Arampatzi, S., Chatzidimitriou, M., & Perifanis, V. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.07.009 · Cited by 63
Crowe, A. P., Jackaman, C., Beddoes, K. M., Ricciardo, B., & Nelson, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073684 · Cited by 61
Magistrato, A., Pavlin, M., Qasem, Z., & Ruthstein, S. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.05.002 · Cited by 61
Insights into the management of Wilson’s disease
Kathawala, M., & Hirschfield, G. M. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17731520 · Cited by 57
12. COPPER DEPLETION AS A THERAPEUTIC STRATEGY IN CANCER
Lopez, J., Ramchandani, D., & Vahdat, L. T. (2019) · De Gruyter eBooks · doi:10.1515/9783110527872-012 · Cited by 55
Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma.
Pan, Q., Bao, L., Kleer, C. G., Brewer, G. J., & Merajver, S. D. (2003) · PubMed · Cited by 54
Cox, C., Merajver, S. D., Yoo, S., Dick, R. D., Brewer, G. J., Lee, J. J., & Teknos, T. N. (2003) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.129.7.781 · Cited by 52
DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression
Ismail, I. A., Hs, K., Lee, H.-J., Jk, K., & Sh, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.40 · Cited by 51
Vella, V., Malaguarnera, R., Lappano, R., Maggiolini, M., & Belfiore, A. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.020 · Cited by 50
Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer
Blockhuys, S., Brady, D. C., & Wittung-Stafshede, P. E. (2020) · Breast Cancer · doi:10.1007/s12282-019-01044-4 · Cited by 50
Kim, Y., Tsang, T., Anderson, G. R., Posimo, J. M., & Brady, D. C. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1784 · Cited by 48
Bossak‐Ahmad, K., Drew, S. C., Stefaniak, E., Płonka, D., Bonna, A., & Bal, W. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.01.011 · Cited by 38
Cited by
Copper metabolism in cell death and autophagy
Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023) · Autophagy · doi:10.1080/15548627.2023.2200554 · Cited by 701
Role of Copper on Mitochondrial Function and Metabolism
Ruiz, L. M., Libedinsky, A., & Elorza, A. A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.711227 · Cited by 564
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Oliveri, V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.841814 · Cited by 367
Zhang, Z., Zeng, X., Wu, Y., Liu, Y., Zhang, X., & Song, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.925618 · Cited by 275
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Wang, Y., Chen, Y., Zhang, J., Yang, Y., Fleishman, J. S., Wang, Y., Wang, J., Chen, J., Li, Y., & Wang, H. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101018 · Cited by 256
Self-citation
Metadata
- Authors
- Li, Y.
- Venue
- IUBMB Life
- Publisher
- Wiley
- Published
- 2020-06-29
- Volume
- 72
- Issue
- 9
- Pages
- 1900-1908
- ISSN
- 1521-6543 (ISSN-L)
- 1521-6551
- OpenAlex
- W3040231202
- Cited by
- 282
- References
- 82
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.